139 related articles for article (PubMed ID: 28199737)
1. Inhibition of transient receptor potential vanilloid-1 confers neuroprotection, reduces tumor necrosis factor-alpha, and increases IL-10 in a rat stroke model.
Hakimizadeh E; Shamsizadeh A; Roohbakhsh A; Arababadi MK; Hajizadeh MR; Shariati M; Rahmani MR; Allahtavakoli M
Fundam Clin Pharmacol; 2017 Aug; 31(4):420-428. PubMed ID: 28199737
[TBL] [Abstract][Full Text] [Related]
2. Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
Beider K; Rosenberg E; Dimenshtein-Voevoda V; Sirovsky Y; Vladimirsky J; Magen H; Ostrovsky O; Shimoni A; Bromberg Z; Weiss L; Peled A; Nagler A
J Hematol Oncol; 2020 Nov; 13(1):158. PubMed ID: 33239060
[TBL] [Abstract][Full Text] [Related]
3. TRPV1 receptor-mediated expression of Toll-like receptors 2 and 4 following permanent middle cerebral artery occlusion in rats.
Hakimizadeh E; Shamsizadeh A; Roohbakhsh A; Arababadi MK; Hajizadeh MR; Shariati M; Fatemi I; Moghadam-Ahmadi A; Bazmandegan G; Rezazadeh H; Allahtavakoli M
Iran J Basic Med Sci; 2017 Aug; 20(8):863-869. PubMed ID: 29085577
[TBL] [Abstract][Full Text] [Related]
4. Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath.
Tékus V; Bölcskei K; Kis-Varga A; Dézsi L; Szentirmay E; Visegrády A; Horváth C; Szolcsányi J; Petho G
Eur J Pharmacol; 2010 Sep; 641(2-3):135-41. PubMed ID: 20534382
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease.
Razavinasab M; Shamsizadeh A; Shabani M; Nazeri M; Allahtavakoli M; Asadi-Shekaari M; Esmaeli-Mahani S; Sheibani V
Fundam Clin Pharmacol; 2013 Dec; 27(6):632-40. PubMed ID: 23216087
[TBL] [Abstract][Full Text] [Related]
6. The effect of intra-ventral hippocampus administration of TRPV1 agonist and antagonist on spatial learning and memory in male rats.
Amiresmaili S; Shamsizadeh A; Allahtavakoli M; Pourshanazari AA; Roohbakhsh A
Pharmacol Rep; 2014 Feb; 66(1):10-4. PubMed ID: 24905300
[TBL] [Abstract][Full Text] [Related]
7. Effects of a TRPV1 agonist capsaicin on respiratory rhythm generation in brainstem-spinal cord preparation from newborn rats.
Tani M; Kotani S; Hayakawa C; Lin ST; Irie S; Ikeda K; Kawakami K; Onimaru H
Pflugers Arch; 2017 Feb; 469(2):327-338. PubMed ID: 27900462
[TBL] [Abstract][Full Text] [Related]
8. TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling.
Li S; Bode AM; Zhu F; Liu K; Zhang J; Kim MO; Reddy K; Zykova T; Ma WY; Carper AL; Langfald AK; Dong Z
Carcinogenesis; 2011 May; 32(5):779-85. PubMed ID: 21349818
[TBL] [Abstract][Full Text] [Related]
9. TRPV1 and TRPA1 in Lung Inflammation and Airway Hyperresponsiveness Induced by Fine Particulate Matter (PM
Xu M; Zhang Y; Wang M; Zhang H; Chen Y; Adcock IM; Chung KF; Mo J; Zhang Y; Li F
Oxid Med Cell Longev; 2019; 2019():7450151. PubMed ID: 31281589
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1.
Czikora Á; Lizanecz E; Bakó P; Rutkai I; Ruzsnavszky F; Magyar J; Pórszász R; Kark T; Facskó A; Papp Z; Édes I; Tóth A
Br J Pharmacol; 2012 Mar; 165(6):1801-1812. PubMed ID: 21883148
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats.
Peles S; Medda BK; Zhang Z; Banerjee B; Lehmann A; Shaker R; Sengupta JN
Neuroscience; 2009 Jun; 161(2):515-25. PubMed ID: 19324074
[TBL] [Abstract][Full Text] [Related]
12. Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats.
Rajpal S; Gerovac TA; Turner NA; Tilghman JI; Allcock BK; McChesney SL; Miranpuri GS; Park SW; Resnick DK
J Neurosurg Spine; 2007 May; 6(5):420-4. PubMed ID: 17542507
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of SA13353 [1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia/reperfusion-induced renal injury in rats.
Ueda K; Tsuji F; Hirata T; Ueda K; Murai M; Aono H; Takaoka M; Matsumura Y
J Pharmacol Exp Ther; 2009 Apr; 329(1):202-9. PubMed ID: 19147859
[TBL] [Abstract][Full Text] [Related]
14. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord.
Kamata Y; Kambe T; Chiba T; Yamamoto K; Kawakami K; Abe K; Taguchi K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570786
[TBL] [Abstract][Full Text] [Related]
16. The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.
Alawi KM; Aubdool AA; Liang L; Wilde E; Vepa A; Psefteli MP; Brain SD; Keeble JE
FASEB J; 2015 Oct; 29(10):4285-98. PubMed ID: 26136480
[TBL] [Abstract][Full Text] [Related]
17. A Single Injection of
Tejada de Rink MM; Naumann U; Kollmar R; Schwab S; Dietel B; Harada H; Tauchi M
Ther Hypothermia Temp Manag; 2020 Jun; 10(2):91-101. PubMed ID: 31084468
[TBL] [Abstract][Full Text] [Related]
18. Ethanol contributes to neurogenic pancreatitis by activation of TRPV1.
Vigna SR; Shahid RA; Liddle RA
FASEB J; 2014 Feb; 28(2):891-6. PubMed ID: 24221085
[TBL] [Abstract][Full Text] [Related]
19. Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats.
Hoffmeister C; Trevisan G; Rossato MF; de Oliveira SM; Gomez MV; Ferreira J
Pain; 2011 Aug; 152(8):1777-1788. PubMed ID: 21550723
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential vanilloid 1 (TRPV1) inhibition is related to the suppression of inflammation-associated hypermelanosis.
Moon IJ; Bang SH; Song Y; Chang SE
J Dermatol Sci; 2020 Apr; 98(1):65-68. PubMed ID: 32147196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
